Company Filing History:
2 out of 444 
1 out of 1,187 
Years Active: 2010-2012
Title: The Innovations of William Balch
Introduction
William Balch is a notable inventor based in San Diego, CA, who has made significant contributions to the field of biotechnology. He holds 2 patents that focus on innovative methods for gene modulation and therapeutic applications. His work has implications for treating diseases linked to specific gene expressions.
Latest Patents
One of Balch's latest patents is centered on RNA interference (RNAi) modulation of the Aha gene, specifically the Aha1 gene. This invention involves a double-stranded ribonucleic acid (dsRNA) designed to inhibit the expression of the Aha gene. The dsRNA comprises an antisense strand with a nucleotide sequence that is generally between 19 to 25 nucleotides in length and is substantially complementary to a part of the Aha gene. Additionally, the patent includes a pharmaceutical composition that combines the dsRNA with a pharmaceutically acceptable carrier. The methods outlined in this patent aim to treat diseases caused by Aha1 expression and provide techniques for inhibiting the expression of the Aha gene in cells.
Career Highlights
Throughout his career, William Balch has worked with prominent organizations such as Alnylam Pharmaceuticals, Inc. and The Scripps Research Institute. His experience in these institutions has allowed him to collaborate on groundbreaking research and development projects in the biotechnology sector.
Collaborations
Some of Balch's notable coworkers include Rainer Constien and Birgit Bramlage. Their collaborative efforts have contributed to advancements in the understanding and application of RNAi technology.
Conclusion
William Balch's innovative work in gene modulation and therapeutic applications highlights his significant role in biotechnology. His patents and collaborations reflect a commitment to advancing medical science and improving treatment options for various diseases.